Yes, and I've stated before that I think the notification requirement is very important. I don't think it imposes an undue burden.
On April 23rd, 2007. See this statement in context.
On April 23rd, 2007. See this statement in context.
April 23rd, 2007 / 5:25 p.m.
Vice-President, Corporate Affairs, Eli Lilly Canada Inc.; Canada's Research-Based Pharmaceutical Companies (Rx&D)
Yes, and I've stated before that I think the notification requirement is very important. I don't think it imposes an undue burden.
See context to find out what was said next.